Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson disease

Medical Science Monitor

Volumn 11, Issue 3, 2005, Pages

  Goberman, Alexander M ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

Axial symptoms; Levodopa; Movement; Parkinson disease; Speech

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BODY POSTURE; BRADYKINESIA; CLINICAL ARTICLE; FACIAL EXPRESSION; FEMALE; GAIT; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PHONATION; SPEECH; SPEECH DISORDER;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CARBIDOPA; DEEP BRAIN STIMULATION; FEMALE; GAIT; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR SKILLS; MOTOR SKILLS DISORDERS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SPEECH ACOUSTICS; TIME FACTORS;

EID: 15944380753     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. nd ed.). New York: Oxford University Press, 1998
2. Lang A, Lozano A: Parkinson's disease: First of two parts. New Engl J Med, 1998; 339: 1044-53
3. Riederer P: Views on neurodegeneration as a basis for neuroprotective strategies. Med Sci Monit, 2004; 10(12): RA287-RA290
4. Simuni T, Hurtig H: Levodopa: 30 years of progress. In: Factor S, Weiner W, editors. Parkinson's disease: Diagnosis and clinical management. New York: Demos Publishing; 2002; p. 339-56
5. Koller W, Pahwa R, Lyons K, Albanese A: Surgical treatment of Parkinson's disease. J Neurosurg Sci, 1999; 167: 1-10
6. Goberman A, Coelho C, Robb M: Phonatory characteristics of Parkinsonian speech before and after morning medication: The ON and OFF states. J Commun Disord, 2002; 35: 217-39
7. Goberman A, Blomgren M: Parkinsonian speech disfluencies: Effects of L-Dopa-related fluctuations. J Fluency Disord, 2003; 28: 55-70
8. Goberman A, Coelho C, Robb M: Prosodic characteristics of Parkinsonian speech: The effect of levodopa-based medication. J Med Speech Lang Path. In Press, 2005
9. Dromey C, Kumar R, Lang A, Lozano A: An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord, 2000; 15: 1132-38
10. Rousseaux M, Krystkowiak P, Kozlowski O et al: Effects of subthalamic stimulation on Parkinsonian dysarthria and speech intelligibility. J Neurol, 2004; 354: 327-34
11. Romito L, Scerrati M, Contarino M et al: Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology, 2002; 28: 1546-50
12. Wang E, Metman L, Bakay R et al: The effect of unilateral electrostimulation of the subthalamic nucleus on respiratory/phonatory subsystems of speech production in Parkinson's diseases preliminary report. Clin Linguist Phon, 2003; 17: 283-89
13. Krack P, Batir A, Ven Blercom N et al: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med, 2003; 349: 1925-34
14. Simuni T, Jaggi K, Mulholland H et al: Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg, 2002; 96: 666-72
15. Hristova A, Lyons K, Troster A et al: Effect and time course of deep brain stimulation of the globus pallidus and subthalamus on motor features of Parkinson's disease. Clin Neuropharmacol, 2000; 23: 208-11
16. Thobois S, Mertens P, Guenot M et al: Subthalamic nucleus stimulation in Parkinson's disease: Clinical evaluation of 18 patients. J Neurol, 2002; 249: 529-34
17. Santens P, De Letter M, Borsel J et al: Lateralized effects of subthalamic nucleus stimulation on different aspects of Parkinson's disease. Brain Lang, 2003; 87: 253-58
18. Gentil M, Garcia-Ruiz P, Pollak P, Benabid A: Effect of bilateral deep-brain stimulation on oral control of padents with Parkinsonism. Eur Neurol, 2000; 44: 147-52
19. Hoffman-Ruddy B, Schulz G, Vitek J, Evatt M: A preliminary study of the effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on voice and speech characteristics in Parkinson's disease (PD). Clin Linguist Phon, 2001; 15: 97-101
20. Pinto S, Thobois S, Costes N et al: Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: A PET study. Brain, 2004; 127: 602-15
21. Quaglieri C, Celesia G: Effect of Thalamotomy and Levodopa therapy on the speech of Parkinson patients. Europ J Neurol, 1977; 15: 34-39
22. Rigrodsky S, Morrison E: Speech changes in Parkinsonism during L-Dopa therapy: preliminary findings. J Am Geriatrics Soc, 1970; 18: 142-51
23. Poluha P, Teulings H, Brookshire R: Handwriting and speech changes across the levodopa cycle in Parkinson's disease. Acta Psychol, 1998; 100: 71-84
24. Larson K, Ramig L, Scherer R: Acoustic and glottographic voice analysis during drug-related fluctuations in Parkinson disease. J Med Speech-Lang Path, 1994; 2: 227-39
25. Gurd J, Bessell N, Watson I, Coleman J: Motor speech versus digit control in Parkinson's disease: a cognitive neuropsychology investigation. Clin Linguist Phon, 1998; 12: 357-78
26. Nakano K, Zubick H, Tyler H: Speech defects of parkinsonian patients: Effects of levodopa therapy on speech intelligibility. Neurology, 1973; 23: 865-70
27. Wolfe V, Garvin J, Bacon M, Waldrop W: Speech changes in Parkinson's Disease during treatment with L-Dopa. J Commun Disord, 1975; 8: 271-79
28. Sanabria J, Ruiz P, Gutierrez R et al: The effect of levodopa on vocal function in Parkinson's disease. Clin Neuropharm, 2002; 24: 99-102
29. Jiang J, Lin E, Wang J, Hanson D: Glottographic measures before and after levodopa treatment in Parkinson's disease. Laryngoscope, 1999; 109: 1287-94
30. Rascol O, Payoux P, Ory F et al: Limitations of Current Parkinson's disease therapy. Ann Neurol, 2003; 53(Suppl.3): S3-S15
31. Klawans H: Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord, 1986; 1: 187-92
32. Steiger M, Thompson P, Marsden C: Disordered axial movement in Parkinson's disease. J Neurol Neurosurg Psychiatry, 1996; 61: 645-48
33. Bejjani B, Gervais D, Arnulf I et al: Axial parkinsonian symptoms can be improved: The role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry, 2000; 68: 595-600
34. Stebbins G, Goetz C: Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination Section. Mov Disord, 1998; 13: 633-36
35. Fahn S, Elton R, members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M, Editors. Recent Developments in Parkinson's Disease, volume 2. Florham Park, NJ: Macmillan Health-Care Information;1987; p. 153-63
36. Ludlow C, Bassich C: Relationships between perceptual ratings and acoustic measures of hypokinetic speech. In McNeil M, Rosenbeck J, Aronson A, Editors. The Dysarthrias: Physiology, Acoustics, Perception, Management. San Diego: College-Hill Press; 1984; p. 186-95
37. Brown P, Corcos D, Rothwell J: Does parkinsonian action tremor contribute to muscle weakness in Parkinson's disease? Brain, 1997; 120: 401-8
38. Tjaden K: A preliminary study of factors influencing perception of articulatory rate in Parkinson disease. J Speech Hear Res, 2000; 43: 997-1010
39. Solomon N, Hixon T: Speech breathing in Parkinson's disease. J Speech Hear Res, 1993; 36: 294-310
40. Lang A, Lozano A: Parkinson's disease: Second of two parts. New Engl J Med, 1998; 339: 1130-43
41. Bennett D, Shannon K, Beckett L et al: Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology, 1997; 49: 1580-87
42. Siderowf A, McDermott M, Kieburtz K et al. the Parkinson Study Group: Test-Retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trial. Mov Disord, 2002; 17: 758-63